On the use of micron-sized iron oxide particles (MPIOS) to label resting monocytes in bone marrow

Kevin S Tang1, Bradley Hann, Erik M Shapiro

  • 1Department of Biomedical Engineering, Yale University School of Medicine, New Haven, CT, USA.

Abstract

Insights

Micron-sized iron oxide particles (MPIOs) can label monocytes in culture but fail to label bone marrow monocytes in vivo. This study investigates MPIOs for immune cell tracking in mice.

Area of Science:

  • Biomedical imaging
  • Immunology
  • Nanotechnology

Background:

  • Magnetic Resonance Imaging (MRI) is used to track immune cells in diseases.
  • Micron-sized iron oxide particles (MPIOs) are investigated for enhanced magnetic labeling of immune cells.
  • Previous studies utilized (U)SPIO for similar applications.

Purpose of the Study:

  • To assess the efficacy of intravenously administered MPIOs in labeling bone marrow resident monocytes in mice.
  • To evaluate the potential of MPIOs as a tool for in vivo immune cell tracking.

Main Methods:

  • MPIOs were incubated with immune cells in culture and whole blood.
  • Flow cytometry and histology were used to analyze cell labeling.
  • In vivo MRI was performed on mouse legs after MPIO injection.
  • Bone marrow cells were analyzed for MPIO labeling.

Main Results:

  • Monocytes and neutrophils successfully endocytosed MPIOs in vitro and ex vivo.
  • MPIOs rapidly accumulated in bone marrow post-injection.
  • No labeling of bone marrow monocytes or other hematopoietic cells by MPIOs was observed in vivo.
  • MPIOs remained in bone marrow for at least 7 days with slow clearance.

Conclusions:

  • Systemic MPIO administration leads to rapid bone marrow accumulation.
  • Despite in vitro labeling capability, MPIOs do not label bone marrow monocytes in vivo.
  • Further research is needed to understand the in vivo labeling limitations of MPIOs for immune cell tracking.

Related Concept Videos